ATE403725T1 - Cap-bindungsprotein - Google Patents

Cap-bindungsprotein

Info

Publication number: ATE403725T1
Authority: AT; Austria
Prior art keywords: agent; polypeptide; screening; improving; insulin resistance
Prior art date: 2002-10-11

Application number

AT03751421T

Other languages

English (en)

Inventor

Tamaki Oda

Hideki Endoh

Yoshitaka Ueda

Kazunori Inabe

Original Assignee

Astellas Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-11

Filing date

2003-10-09

Publication date

2008-08-15

2003-10-09 Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc

2008-08-15 Application granted granted Critical

2008-08-15 Publication of ATE403725T1 publication Critical patent/ATE403725T1/de

Links

102000028391 RNA cap binding Human genes 0.000 title 1
108091000106 RNA cap binding Proteins 0.000 title 1
239000003795 chemical substances by application Substances 0.000 abstract 4
229920001184 polypeptide Polymers 0.000 abstract 4
102000004196 processed proteins & peptides Human genes 0.000 abstract 4
108090000765 processed proteins & peptides Proteins 0.000 abstract 4
206010022489 Insulin Resistance Diseases 0.000 abstract 3
230000004153 glucose metabolism Effects 0.000 abstract 3
238000012216 screening Methods 0.000 abstract 3
208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 3
239000013604 expression vector Substances 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
102000040430 polynucleotide Human genes 0.000 abstract 2
108091033319 polynucleotide Proteins 0.000 abstract 2
239000002157 polynucleotide Substances 0.000 abstract 2
102000004169 proteins and genes Human genes 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
238000010348 incorporation Methods 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
210000002027 skeletal muscle Anatomy 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Emergency Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Investigating Or Analysing Biological Materials (AREA)

AT03751421T 2002-10-11 2003-10-09 Cap-bindungsprotein ATE403725T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2002298549		2002-10-11

Publications (1)

Publication Number	Publication Date
ATE403725T1 true ATE403725T1 (de)	2008-08-15

Family

ID=32089315

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03751421T ATE403725T1 (de)	2002-10-11	2003-10-09	Cap-bindungsprotein

Country Status (9)

Country	Link
US (1)	US7141650B2 (de)
EP (1)	EP1557465B1 (de)
JP (1)	JP4419077B2 (de)
AT (1)	ATE403725T1 (de)
AU (1)	AU2003271150A1 (de)
CA (1)	CA2501875A1 (de)
DE (1)	DE60322733D1 (de)
ES (1)	ES2309332T3 (de)
WO (1)	WO2004033688A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7833716B2 (en)	2006-06-06	2010-11-16	Gen-Probe Incorporated	Tagged oligonucleotides and their use in nucleic acid amplification methods
US20090038024A1 (en) *	2007-06-19	2009-02-05	The Regents Of The University Of California	Cap/sorbs1 and diabetes
CA3014308A1 (en)	2016-02-11	2017-08-17	Nutrition 21, Llc	Chromium containing compositions for improving health and fitness

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003023002A2 (en) *	2001-09-07	2003-03-20	Curagen Corporation	Novel human proteins, polynucleotides encoding them and methods of using the same

2003
- 2003-10-09 CA CA002501875A patent/CA2501875A1/en not_active Abandoned
- 2003-10-09 AU AU2003271150A patent/AU2003271150A1/en not_active Abandoned
- 2003-10-09 DE DE60322733T patent/DE60322733D1/de not_active Expired - Lifetime
- 2003-10-09 JP JP2004542859A patent/JP4419077B2/ja not_active Expired - Fee Related
- 2003-10-09 AT AT03751421T patent/ATE403725T1/de not_active IP Right Cessation
- 2003-10-09 WO PCT/JP2003/012968 patent/WO2004033688A1/ja not_active Ceased
- 2003-10-09 EP EP03751421A patent/EP1557465B1/de not_active Expired - Lifetime
- 2003-10-09 US US10/530,886 patent/US7141650B2/en not_active Expired - Fee Related
- 2003-10-09 ES ES03751421T patent/ES2309332T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU2003271150A1 (en)	2004-05-04
WO2004033688A1 (ja)	2004-04-22
DE60322733D1 (de)	2008-09-18
JP4419077B2 (ja)	2010-02-24
JPWO2004033688A1 (ja)	2006-02-09
ES2309332T3 (es)	2008-12-16
EP1557465A1 (de)	2005-07-27
US7141650B2 (en)	2006-11-28
CA2501875A1 (en)	2004-04-22
US20060008857A1 (en)	2006-01-12
EP1557465A4 (de)	2006-06-07
EP1557465B1 (de)	2008-08-06

Similar Documents

Publication	Publication Date	Title
WO2005019256A3 (en)	2005-07-21	Muteins of tear lipocalin
DE602005021372D1 (de)	2010-07-01	Zusammensetzung in mikropellets mit kontrollierter freisetzung von physiologischen wirksubstanzen, verfahren zu ihrer herstellung und ihre verwendung im zootechnischen sektor
AU2001254624A1 (en)	2001-11-12	Human coagulation factor vii variants
DE602004030464D1 (de)	2011-01-20	Methode zur produktion und evaluierung der zytotoxizität von kir2dl nk-rezeptor antikörpern
WO2000024365A8 (en)	2001-02-08	Treatment of skin with adenosine or adenosine analog
SG161234A1 (en)	2010-05-27	A method and composition for nutritionally improving glucose control and insulin action
AU2003266214A1 (en)	2004-04-19	Human coagulation factor vii polypeptides
DE60027409D1 (de)	2006-05-24	Glykosylierte leptinzusammensetzungen und zugehörige verfahren
AU2003903124A0 (en)	2003-07-10	Analogues of heteromeric proteins
PT1660115E (pt)	2011-08-24	ASSOCIAÇÃO FARMACjUTICA DE G-CSF E DE PLGF ÚTIL NA MOBILIZAÇÃO DE CÉLULAS ESTAMINAIS DO SANGUE
EP0992586A3 (de)	2004-04-21	Extrazelluläre Matrixproteine mit modifizierten Aminosäuren
ATE403725T1 (de)	2008-08-15	Cap-bindungsprotein
WO2007060213A3 (en)	2008-08-14	Erythropoietin polypeptides and uses thereof
WO2004053092A3 (en)	2004-09-10	Human pellino polypeptides
AU2003289186A1 (en)	2004-06-23	PROTEIN BINDING TO Akt2
DE602004030781D1 (de)	2011-02-10	Gefriergetrocknetes präparat mit methylcobalamin und verfahren zu seiner herstellung
WO2003082897A3 (en)	2003-12-18	Synthetic active peptide fragments
DE60122701D1 (de)	2006-10-12	Kosmetische oder dermatologische cremezubereitung, deren herstellung und verwendung
WO2007027092A3 (en)	2007-05-10	Oral composition for moisturising skin
WO2005097830A3 (en)	2005-12-22	Uses of isolated binding members capable of reducing the biological activity of secretagogue compounds
WO2004056982A3 (en)	2004-09-16	Kinase sequences
BRPI0517004A (pt)	2008-09-30	produto alimentìcio contendo um ou vários microorganismos vivos e pelo menos um ingrediente alimentìcio bioativo de interesse, processo de preparação do mesmo e utilizações de um produto alimentìcio e de pelo menos um ingrediente alimentìcio isca
CA2405265A1 (en)	2001-10-25	Method of preventing or treating diabetes
ATE460918T1 (de)	2010-04-15	Zusammensetzung und deren verwendung als pharmazeutische oder kosmetische formulierung zur äusserlichen anwendung
WO2004028442A3 (en)	2004-07-15	Use of excipients to increase dna uptake by swine muscle cells

Legal Events

Date	Code	Title	Description
2009-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties